PP
PDT Partners’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-50,060
| Closed | -$2.7M | – | 735 |
|
|
2024
Q2 | $2.7M | Buy |
50,060
+32,654
| +188% | +$1.76M | 0.26% | 130 |
|
|
2024
Q1 | $1.19M | Buy |
+17,406
| New | +$1.19M | 0.11% | 299 |
|
|
2023
Q1 | – | Sell |
-26,965
| Closed | -$1.1M | – | 596 |
|
|
2022
Q4 | $1.1M | Buy |
26,965
+4,045
| +18% | +$164K | 0.18% | 197 |
|
|
2022
Q3 | $1.5M | Sell |
22,920
-3,818
| -14% | -$250K | 0.23% | 120 |
|
|
2022
Q2 | $1.63M | Buy |
26,738
+18,239
| +215% | +$1.11M | 0.14% | 224 |
|
|
2022
Q1 | $533K | Buy |
+8,499
| New | +$533K | 0.05% | 568 |
|
|
2021
Q4 | – | Sell |
-7,906
| Closed | -$885K | – | 893 |
|
|
2021
Q3 | $885K | Buy |
+7,906
| New | +$885K | 0.06% | 366 |
|
|
2021
Q1 | – | Sell |
-5,300
| Closed | -$811K | – | 793 |
|
|
2020
Q4 | $811K | Buy |
+5,300
| New | +$811K | 0.05% | 365 |
|
|
2020
Q3 | – | Sell |
-3,215
| Closed | -$236K | – | 741 |
|
|
2020
Q2 | $236K | Buy |
+3,215
| New | +$236K | 0.02% | 569 |
|